1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3369)
  2. Meeting Abstract (1544)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5502)
  2. GSK Faculty (5304)
  3. Sloan Kettering Institute Faculty (3443)
  4. Tow Center for Developmental Oncology (TCDO) (2540)
  5. Department of Medicine (2432)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1823)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (426)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (148)
  3. 2023 (248)
  4. 2022 (307)
  5. 2021 (289)
  6. 2020 (328)

More Years

Publications
  1. Blood (629)
  2. Cancer Research (188)
  3. Journal of Clinical Oncology (168)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (659)
  2. Nature Publishing Group (525)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (366)
  5. Cell Press (354)
  6. Springer (202)

More Publishers

Results (5502)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A risk-adapted study to assess the efficacy of enasidenib and subsequent response-driven addition of azacitidine for newly diagnosed IDH2-mutant AML patients: 3-year follow-up
    Meeting Abstract

    Stein, E.; Cai, S. F.; Huang, Y.; Dunbar, A.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W. G.; Schiller, G. J.; Olin, R. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Unmatched whole-genome sequencing as a clinical tool for hematological neoplasms with significant utility in cases with tumor-in-normal contamination
    Meeting Abstract

    Gutiérrez-Abril, J.; Leongamornlert, D.; Shukla, N. N.; Sulis, M. L.; Zhou, Y.; Levine, M. F.; Barretta, E.; Lee, S.; Arango-Ossa, J. E.; Gundem, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • JAK2(V617F) reversible activation shows an essential requirement for JAK2(V617F) in myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Dunbar, A.; Bowman, R. L.; Park, Y.; Izzo, F.; Myers, R. M.; Karzai, A.; Kim, W. J.; Maestre, I. F.; Waarts, M. R.; Nazir, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Dual IKZF2, and CK1α degrader targets acute myeloid leukemia cells
    Meeting Abstract

    Park, S. M.; Miyamoto, D.; Han, G.; Chan, M.; Curnutt, N.; Tran, N.; Velleca, A.; Kim, J. H.; Schurer, A.; Chang, K.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • PIK3CA hotspot mutation generates a shared neoantigen targetable by TCR gene therapy
    Editorial

    Klebanoff, C. A.; Chandran, S. S.
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • New York Stem Cell Foundation Robertson investigators
    Editorial

    McKinley, K. L.; van Boxtel, R.; Finley, L. W. S.; Peña, C. J.; Nowakowski, T. J.
    Cell Stem Cell (2022)

    Fulltext@MSK | Save
  • Combined single cell atlasing and organoid modeling reveal progressive plasticity during human colorectal cancer metastasis
    Meeting Abstract

    Ganesh, K.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: Analysis of 210 patients from the UKALL14 and UKALL60+clinical trials
    Journal Article

    Creasey, T.; Barretta, E.; Ryan, S. L.; Butler, E.; Kirkwood, A. A.; Leongamornlert, D.; Papaemmanuil, E.; Patrick, P.; Clifton-Hadley, L.; Patel, B.; more...
    Haematologica (2022)

    Fulltext@MSK | Save
  • Durvalumab (D) + platinum-etoposide (EP) in 1L extensivestage small-cell lung cancer (ES-SCLC): Exploratory analysis of SCLC molecular subtypes in CASPIAN
    Meeting Abstract

    Xie, M.; Chugh, P.; Broadhurst, H.; Lai, Z.; Whitston, D.; Paz-Ares, L.; Gay, C.; Byers, L.; Rudin, C. M.; Stewart, R.; more...
    Oncology Research and Treatment (2022)

    Fulltext@MSK | Save
  • Permanent carrier-embedded Cesium-131 brachytherapy for the salvage treatment of previously irradiated, recurrent brain metastases
    Meeting Abstract

    Imber, B.; Beal, K.; Reiner, A.; Giantini-Larsen, A.; Yang, J.; Aramburu-Nunez, D.; Cohen, G.; Brennan, C.; Tabar, V.; Young, R.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save